Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail)

v3.22.1
Net Loss Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail) - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 15,097,085 14,252,787
Employee Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 4,171,919 1,925,197
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 10,925,166 12,327,590